HOLLINGS RENTON
CIK 1187333 · President and CEO · last filed 2026-04-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$852.0K
Companies
8
Total Filings
83
Lifetime Open-Market Net
-$15.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANAB | Director | 15,196 | $56.07 | $852.0K | -$1.37M | 18 | 2026-04-22 |
| ZYME | Director | — | $22.88 | — | $0 | 5 | 2023-12-08 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 0 | — | — | -$875.4K | 14 | 2020-07-02 |
| CEPHEID (CPHD) Delisted | Director | 0 | — | — | -$4.29M | 23 | 2016-11-07 |
| KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Director | — | — | — | $0 | 3 | 2015-10-02 |
| RIGL | Director | — | $32.85 | — | $0 | 7 | 2013-05-28 |
| AFFYMAX INC (AFFY) Delisted | Director | — | — | — | $0 | 4 | 2012-06-18 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | President and CEO | 232,490 | — | — | -$8.55M | 9 | 2008-02-26 |
Recent Filings · Page 2 of 9
83 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-05 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2023-12-08 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2023-01-10 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2022-12-23 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2022-02-14 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2021-05-07 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2021-02-12 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2020-07-02 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Disp (D) | −23,301 | -$419.4K | EDGAR |
| 2020-06-15 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Grant (A) | +7,281 | $0 | EDGAR |
| 2020-05-12 | ZYME | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.